Funder
Natural Science Foundation of Hunan Province
National Natural Science Foundation of China
Reference29 articles.
1. A combination of stromal PD‐L1 and tumoral nuclear β‐catenin expression as an indicator of colorectal carcinoma;Takahashi;progression and resistance to chemoradiotherapy in locally advanced rectal carcinoma,2022
2. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations;Zou;Sci. Transl. Med.,2016
3. Review of PD-1/PD-L1 inhibitors in metastatic dMMR/MSI-H colorectal cancer;Oliveira;Front. Oncol.,2019
4. Clinical trial data of Anti-PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: a review;Adkins;Cancer Treat Rev.,2022